Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Medicinal Chemistry
|
February 3, 2022
In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
Muya Xiong, Tianqing Nie, Qiang Shao, et al.
Steroids
|
December 15, 2023
Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2
Yaowen Liu, Tianqing Nie, Jinjun Hou, et al.
Journal of Chemical Information and Modeling
|
November 28, 2024
Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations
Muya Xiong, Tianqing Nie, Zhewen Li, et al.
Angewandte Chemie (International Ed. in English)
|
December 1, 2021
Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
Xiangbo Yang, Huimin Lu, Hang Xie, et al.
Journal of Virology
|
April 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir
Lu Chen, Haixia Su, Weijuan Shang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 7, 2025
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease
Haixia Su, Guoqing Wu, Muya Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 13, 2025
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors
Haixia Su, Tianqing Nie, Guofeng Chen, et al.
Journal of Medicinal Chemistry
|
August 18, 2023
Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group
Pengxuan Ren, Hui Li, Tianqing Nie, et al.
European Journal of Medicinal Chemistry
|
January 26, 2023
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
Pengxuan Ren, Changyue Yu, Ruxue Zhang, et al.
Journal of Medicinal Chemistry
|
July 29, 2024
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CL<sup>pro</sup> Inhibitors as anti-SARS-CoV-2 Drug Candidate
Zhidong Jiang, Bo Feng, Lu Chen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Medicinal Chemistry
|
February 3, 2022
In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
Muya Xiong, Tianqing Nie, Qiang Shao, et al.
Steroids
|
December 15, 2023
Design, synthesis and biological evaluation of betulinic acid derivatives as potential inhibitors of 3CL-protease of SARS-CoV-2
Yaowen Liu, Tianqing Nie, Jinjun Hou, et al.
Journal of Chemical Information and Modeling
|
November 28, 2024
Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations
Muya Xiong, Tianqing Nie, Zhewen Li, et al.
Angewandte Chemie (International Ed. in English)
|
December 1, 2021
Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
Xiangbo Yang, Huimin Lu, Hang Xie, et al.
Journal of Virology
|
April 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir
Lu Chen, Haixia Su, Weijuan Shang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 7, 2025
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease
Haixia Su, Guoqing Wu, Muya Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
December 13, 2025
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors
Haixia Su, Tianqing Nie, Guofeng Chen, et al.
Journal of Medicinal Chemistry
|
August 18, 2023
Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive Group
Pengxuan Ren, Hui Li, Tianqing Nie, et al.
European Journal of Medicinal Chemistry
|
January 26, 2023
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
Pengxuan Ren, Changyue Yu, Ruxue Zhang, et al.
Journal of Medicinal Chemistry
|
July 29, 2024
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CL<sup>pro</sup> Inhibitors as anti-SARS-CoV-2 Drug Candidate
Zhidong Jiang, Bo Feng, Lu Chen, et al.
Page
of 2